GOV.UK
Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Drug Analysis Prints (DAPs)
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance and publications about a possible no-deal Brexit
Information about the regulation of medicines and medical devices if there is a no-deal Brexit.
Press release
MHRA and the Bill & Melinda Gates Foundation to look at the safer, effective use of medicines during pregnancy
MHRA and the Bill & Melinda Gates Foundation have begun new research on medicine use which could impact the health of pregnant women around the world.
Press release
HRT users to discuss risks and benefits at next appointment as new study highlights persistent risk of breast cancer
Women who are current or past users of hormone replacement therapy (HRT) to treat symptoms of the menopause are reminded to be vigilant for signs of breast cancer, even after stopping HRT.
News story
Dr June Raine to become interim Chief Executive Officer
Dr June Raine will become interim Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) from 20 September 2019.
Press release
Patients to check if they have certain prescription-only medicines as additional products recalled
As a precautionary measure, patients taking certain types of prescription-only medicines for Parkinson’s (Neupro) and epilepsy (Vimpat) are asked to check to see if they have products from batches of medicines which are being recalled.
Press release
MHRA launches consultation on how to best engage patients and the public
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a 12-week consultation on how to best engage and involve patients in the Agency’s work.
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- Strategy for pharmacopoeial public quality standards for biological medicines
- How should we engage and involve patients and the public in our work
Transparency and freedom of information releases
- MHRA: requests under the Freedom of Information Act (FOIA)
- Medicines and Healthcare products Regulatory Agency spending over £25,000: 2019 to 2020
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts